OVIGYN DSR contain Dehydroepiandrosterone which belongs to a group of medicine called steroids. It is used for women with having ovary with less reproductive potential and responding poorly in vitro fertilization (IVF). Dehydroepiandrosterone is produced by the outer layer of the adrenal glands, known as the adrenal cortex. It is an important source of oestrogens in the women which provides maximum percentage of oestrogens before and after menopause.
OVIGYN DSR gets converted into sex hormones in the body which are essential for the production and development of healthy eggs. The common side effects are oily skin, acne-like bumps, excessive hair growth on the face, enhanced perspiration odour, hair loss, mood changes, voice deepening, masculinization symptoms, breast cancer, prostate cancer.
Always take OVIGYN DSR exactly as your doctor has told you. This medicine must be taken with or without food and try to take at the same time each day. It should be swallowed whole with water. Do not crush or chew the medicine. Before taking this medicine tell your doctor if you have ever had kidney disease, heart disease, liver problems. Pregnant and breastfeeding women should consult their doctor before taking this medicine. The common side effects are oily skin, acneiform dermatitis, facial hirsutism, enhanced perspiration odour, acne and hair loss.
It gets converted into sex hormones in the body which are essential for the production and development of healthy eggs.
Always take OVIGYN DSR exactly as your doctor has told you. It must be taken with or without food and try to take at the same time each day. It should be swallowed whole with water. Do not crush or chew the medicine. The recommended dose is one tablet once a day.
OVIGYN DSR is not recommended for use in pregnant women unless necessary. Discuss the risks and benefits with your doctor.
OVIGYN DSR is not recommended for use in breastfeeding women unless necessary. Discuss the risks and benefits with your doctor.
Consumption of alcohol is not recommended during treatment with OVIGYN DSR.
OVIGYN DSR should be used with caution in patients suffering from active kidney diseases. Consult your doctor for advice.
OVIGYN DSR should be used with caution in patients suffering from liver function impairment or active liver diseases. Consult your doctor for advice.
Do not take OVIGYN DSR if you are allergic (hypersensitive) to Dehydroepiandrosterone or any other ingredients in this medicine.
OVIGYN DSR should be used with caution in patients suffering from active heart diseases (ischaemic heart disease). Consult your doctor for advice.
Tell your doctor if you have or had a condition such as,
Talk to your doctor if you are taking,
Drug | : | Dehydroepiandrosterone |
Pharmacological Category | : | Steroids |
Therapeutic Indication | : | Used for women with diminished ovarian reserve and poor responders undergoing in vitro fertilization (IVF) |
Dosage Forms | : | Tablet |
Store below 20-25°C and keep out of reach of children.
Can I take OVIGYN DSR during pregnancy?
No, it is not recommended for use in pregnant women unless necessary. Discuss the risks and benefits with your doctor.
Can stress cause high DHEA levels?
Yes. DHEA concentrations increase in response to both acute and repeated stress.
What does OVIGYN DSR do for fertility?
It promotes early follicle growth and reduce follicle atresia (cell death) leading to an increase in the ovarian response to medications, increased oocyte production and pregnancy rates with IVF.
1. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page - 1062-1064.
2. Meixiang Zhang,1 Wenbin Niu,1 Yu Wang,2 Jiawei Xu,1 Xiao Bao,1 Linlin Wang,1 Linqing Du,1 and Yingpu Suncorresponding author1. Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis. US National Library of Medicines, National Institutes of Health. 19 Apr 2016. [Accessed 31 Dec 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974220/
3. Ciplamed, Mar 2015; Electronic Medicines Compendium (EMC); [Revised on Dec 2015] [Accessed 31 Dec 2020] https://www.ciplamed.com/content/prastova-sr-tablets
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.